Cargando…
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
The bone marrow is the origin of all hematopoietic lineages and an important homing site for memory cells of the adaptive immune system. It has recently emerged as a graft-versus-host disease (GvHD) target organ after allogeneic stem cell transplantation (alloHSCT), marked by depletion of both hemat...
Autores principales: | Szyska, Martin, Na, Il-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811960/ https://www.ncbi.nlm.nih.gov/pubmed/27066008 http://dx.doi.org/10.3389/fimmu.2016.00118 |
Ejemplares similares
-
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
por: Greco, Raffaella, et al.
Publicado: (2019) -
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview
por: Boieri, Margherita, et al.
Publicado: (2016) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022) -
Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
por: Introna, Martino, et al.
Publicado: (2020)